Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs

Detalhes bibliográficos
Autor(a) principal: Guerreiro, Filipa
Data de Publicação: 2021
Outros Autores: Swedrowska, Magda, Patel, Roshnee, Floréz- Fernández, Noelia, Torres, María Dolores, Rosa Da Costa, Ana M., Forbes, Ben, Grenha, Ana
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.1/17805
Resumo: Few medically-approved excipients are available for formulation strategies to endow microcarriers with improved performance in lung drug targeting. Konjac glucomannan (KGM) is a novel, biocompatible material, comprising mannose units potentially inducing macrophage uptake for the treatment of macrophage-mediated diseases. This work investigated spray-dried KGM microparticles as inhalable carriers of model antitubercular drugs, isoniazid (INH) and rifabutin (RFB). The polymer was characterised and different polymer/drug ratios tested in the production of microparticles for which respirability was assessed in vitro. The swelling of KGM microparticles and release of drugs in simulated lung fluid were characterised and the biodegradability in presence of beta-mannosidase, a lung hydrolase, determined. KGM microparticles were drug loaded with 66-91% association efficiency and had aerodynamic diameter around 3 mu m, which enables deep lung penetration. The microparticles swelled upon liquid contact by 40-50% but underwent size reduction (>62% in 90 min) in presence of beta-mannosidase, indicating biodegradability. Finally, drug release was tested showing slower release of RFB compared with INH but complete release of both within 24 h. This work identifies KGM as a biodegradable polymer of natural origin that can be engineered to encapsulate and release drugs in respirable microparticles with physical and chemical macrophage-targeting properties.
id RCAP_bfafb88ac558255af796d8bb01a7ad2e
oai_identifier_str oai:sapientia.ualg.pt:10400.1/17805
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugsInhalationKonjac glucomannanMicroparticlesPulmonary drug deliveryFew medically-approved excipients are available for formulation strategies to endow microcarriers with improved performance in lung drug targeting. Konjac glucomannan (KGM) is a novel, biocompatible material, comprising mannose units potentially inducing macrophage uptake for the treatment of macrophage-mediated diseases. This work investigated spray-dried KGM microparticles as inhalable carriers of model antitubercular drugs, isoniazid (INH) and rifabutin (RFB). The polymer was characterised and different polymer/drug ratios tested in the production of microparticles for which respirability was assessed in vitro. The swelling of KGM microparticles and release of drugs in simulated lung fluid were characterised and the biodegradability in presence of beta-mannosidase, a lung hydrolase, determined. KGM microparticles were drug loaded with 66-91% association efficiency and had aerodynamic diameter around 3 mu m, which enables deep lung penetration. The microparticles swelled upon liquid contact by 40-50% but underwent size reduction (>62% in 90 min) in presence of beta-mannosidase, indicating biodegradability. Finally, drug release was tested showing slower release of RFB compared with INH but complete release of both within 24 h. This work identifies KGM as a biodegradable polymer of natural origin that can be engineered to encapsulate and release drugs in respirable microparticles with physical and chemical macrophage-targeting properties.ElsevierSapientiaGuerreiro, FilipaSwedrowska, MagdaPatel, RoshneeFloréz- Fernández, NoeliaTorres, María DoloresRosa Da Costa, Ana M.Forbes, BenGrenha, Ana2022-05-09T14:37:59Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/17805eng0378-517310.1016/j.ijpharm.2021.120731info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-24T10:29:59Zoai:sapientia.ualg.pt:10400.1/17805Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:07:39.973861Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs
title Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs
spellingShingle Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs
Guerreiro, Filipa
Inhalation
Konjac glucomannan
Microparticles
Pulmonary drug delivery
title_short Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs
title_full Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs
title_fullStr Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs
title_full_unstemmed Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs
title_sort Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs
author Guerreiro, Filipa
author_facet Guerreiro, Filipa
Swedrowska, Magda
Patel, Roshnee
Floréz- Fernández, Noelia
Torres, María Dolores
Rosa Da Costa, Ana M.
Forbes, Ben
Grenha, Ana
author_role author
author2 Swedrowska, Magda
Patel, Roshnee
Floréz- Fernández, Noelia
Torres, María Dolores
Rosa Da Costa, Ana M.
Forbes, Ben
Grenha, Ana
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Sapientia
dc.contributor.author.fl_str_mv Guerreiro, Filipa
Swedrowska, Magda
Patel, Roshnee
Floréz- Fernández, Noelia
Torres, María Dolores
Rosa Da Costa, Ana M.
Forbes, Ben
Grenha, Ana
dc.subject.por.fl_str_mv Inhalation
Konjac glucomannan
Microparticles
Pulmonary drug delivery
topic Inhalation
Konjac glucomannan
Microparticles
Pulmonary drug delivery
description Few medically-approved excipients are available for formulation strategies to endow microcarriers with improved performance in lung drug targeting. Konjac glucomannan (KGM) is a novel, biocompatible material, comprising mannose units potentially inducing macrophage uptake for the treatment of macrophage-mediated diseases. This work investigated spray-dried KGM microparticles as inhalable carriers of model antitubercular drugs, isoniazid (INH) and rifabutin (RFB). The polymer was characterised and different polymer/drug ratios tested in the production of microparticles for which respirability was assessed in vitro. The swelling of KGM microparticles and release of drugs in simulated lung fluid were characterised and the biodegradability in presence of beta-mannosidase, a lung hydrolase, determined. KGM microparticles were drug loaded with 66-91% association efficiency and had aerodynamic diameter around 3 mu m, which enables deep lung penetration. The microparticles swelled upon liquid contact by 40-50% but underwent size reduction (>62% in 90 min) in presence of beta-mannosidase, indicating biodegradability. Finally, drug release was tested showing slower release of RFB compared with INH but complete release of both within 24 h. This work identifies KGM as a biodegradable polymer of natural origin that can be engineered to encapsulate and release drugs in respirable microparticles with physical and chemical macrophage-targeting properties.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01T00:00:00Z
2022-05-09T14:37:59Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.1/17805
url http://hdl.handle.net/10400.1/17805
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0378-5173
10.1016/j.ijpharm.2021.120731
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133321748283392